This website is being reviewed for updates. Some information is offline. We apologize for any inconvenience.
Skip to main content
Rural Health Information Hub

Rural Health
Resources by Topic: Prescription drug misuse

Vermont Hub-and-Spoke Model of Care For Opioid Use Disorder: Development, Implementation, and Impact
Discusses the development, application, and effectiveness of a hub-and-spoke system of care developed by addiction medicine physicians and public health officials to expand opioid use disorder (OUD) treatment due the continuous shortage of office-based opioid treatment (OBOT) providers in the rural state of Vermont.
Author(s): John R. Brooklyn, Stacey C. Sigmon
Citation: Journal of Addiction Medicine, 11(4), 286-292
Date: 2017
view details
Stem the Tide: Addressing the Opioid Epidemic
Presents a report on various methods hospitals and health systems can use to address the opioid epidemic. Discusses non-opioid pain management, prescribing practices, and treatment for substance use disorders (SUDs), among other topics. Highlights several rural programs and examples throughout.
Date: 2017
Sponsoring organization: American Hospital Association
view details
Medication-Assisted Treatment Models of Care for Opioid Use Disorder in Primary Care Settings
Report details 12 promising medication-assisted treatment (MAT) models for treatment of opioid use disorder in a primary care setting. Discusses rural issues in several models.
Date: 12/2016
Sponsoring organization: Agency for Healthcare Research and Quality
view details
Opioid Overdose Experience, Risk Behaviors, and Knowledge in Drug Users from a Rural Versus an Urban Setting
Highlights a study on the overdose knowledge of opioid users from both rural and urban areas. Details participants' experience with overdosing and their responses to the Brief Opioid Overdose Knowledge (BOOK) questionnaire.
Author(s): Kelly E. Dunn, Frederick S. Barrett, Claudia Yepez-Laubach, et al.
Citation: Journal of Substance Abuse and Treatment, 71, 1-7
Date: 12/2016
view details
Availability of Buprenorphine Treatment in Kentucky
Describes availability of opioid addiction treatment in Kentucky, with breakdowns by metropolitan, micropolitan, and other non-metropolitan areas, and distribution of various medical specialists authorized to prescribe buprenorphine in these areas.
Author(s): Elijah T. Myers, Tyrone F. Borders
Date: 11/2016
Sponsoring organization: University of Kentucky Institute for Rural Health Policy
view details
Pennsylvania Mobile Team Addresses Substance Use Disorders
Features the Addiction Recovery Mobile Outreach Team (ARMOT) program, which supports patients in the recovery process and educates medical staff on addiction and recovery. ARMOT is a collaboration of three hospitals, two substance abuse providers, and the Armstrong-Indiana-Clarion Drug and Alcohol Commission.
Author(s): Allee Mead
Citation: Rural Monitor
Date: 11/2016
Sponsoring organization: Rural Health Information Hub
view details
Rural Opioid Use Disorder Treatment Depends on Family Physicians
Brief description of a study examining distribution of physicians approved to prescribe buprenorphine for opioid use disorder, by specialty and rurality. Features breakdowns by family medicine, emergency medicine, internal medicine, psychiatry, and all other specialties, and by urban or rural location.
Author(s): Peter Wingrove, Brian Park, Andrew Bazemore
Citation: American Family Physician, 94(7), 546
Date: 10/2016
Sponsoring organization: Robert Graham Center
view details
Opioid Addiction: Laws, Regulations, and Other Factors Can Affect Medication-Assisted Treatment Access
Examines current federal laws and regulations related to the medication-assisted treatment (MAT) of opioid dependency, and discusses how these laws affect access to treatment, including in rural areas. Also explores other factors that affect access to treatment such as cost, insurance coverage, practitioner availability, and perceived value. Provides detailed descriptions about the uses and concerns of the three medications currently approved by the FDA for use in opioid MAT - methadone, buprenorphine, and naltrexone.
Additional links: Full Report
Date: 09/2016
Sponsoring organization: Government Accountability Office
view details
Results from the 2015 National Survey on Drug Use and Health: Detailed Tables
Provides data on use of illicit drugs, alcohol, and tobacco, trends in substance use disorder and mental health, and access to treatment for youth 12-17 and adults. Features statistics for a variety of demographic and geographic characteristics.
Date: 09/2016
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015
Examines the scope and source of an outbreak of human immunodeficiency virus (HIV) infection due to a single HIV type 1 (HIV-1) strain in a small rural community in Indiana. Discusses how prescription opioid analgesic abuse and the injection of drugs has contributed to the rapid spread of the Hepatitis C virus (HCV) and HIV. Describes how contact tracing was used to develop control measures and offers several recommendations on how to prevent similar outbreaks in the future.
Author(s): Philip J. Peters, Pamela Pontones, Karen W. Hoover, et al.
Citation: New England Journal of Medicine, 375, 229-239
Date: 07/2016
view details